Inability of L22 ribosomal protein alteration to increase macrolide MICs in the absence of efflux mechanism in Haemophilus influenzae HMC-S

Journal of Antimicrobial Chemotherapy

Volumn 54, Issue 2, 2004, Pages 393-400

  Peric, Mihaela ^a,b   Bozdogan, Bülent ^a   Galderisi, Chad ^a   Krissinger, Dan ^a   Rager, Terry ^a   Appelbaum, Peter C ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b PLIVA CROATIA LTD   (Croatia)

Author keywords

H. influenzae; Macrolide efflux; Macrolide resistance; Ribosomal mutations

Indexed keywords

ACRIFLAVINE; AZITHROMYCIN; CLARITHROMYCIN; CLINDAMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; DODECYL SULFATE SODIUM; ERYTHROMYCIN; ETHIDIUM BROMIDE; MACROLIDE; PROTEIN L22; RIBOSOME PROTEIN; RIFAMPICIN; UNCLASSIFIED DRUG; VIRUS DNA;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM MUTANT; BACTERIUM TRANSFORMATION; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG TRANSPORT; GENE CLUSTER; GENE EXPRESSION; GENETIC TRANSCRIPTION; HAEMOPHILUS INFLUENZAE; MINIMUM INHIBITORY CONCENTRATION; MUTATIONAL ANALYSIS; NONHUMAN; RADIOACTIVITY; SEQUENCE ANALYSIS; STRAIN DIFFERENCE;

ANTI-BACTERIAL AGENTS; BLOTTING, SOUTHERN; CLARITHROMYCIN; DNA PRIMERS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; GENES, BACTERIAL; HAEMOPHILUS INFLUENZAE; MACROLIDES; MICROBIAL SENSITIVITY TESTS; MULTIGENE FAMILY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN CONFORMATION; RIBOSOMAL PROTEINS; RNA, BACTERIAL; TRANSFORMATION, BACTERIAL;

EID: 4444270519     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh364     Document Type: Article

References (14)

1. Koebnik, R., Locher, K. P. & Van Gelder, P. (2000). Structure and function of bacterial outer membrane proteins: barrels in a nutshell. Molecular Microbiology 37, 239-53.
2. Peric, M., Bozdogan, B., Jacobs, M. R. et al. (2003). Effects of an efflux mechanism and ribosomal mutations on macrolide susceptibility of clinical isolates of Haemophilus influenzae. Antimicrobial Agents and Chemotherapy 47, 1017-22.
3. Clark, C., Bozdogan, B., Peric, M. et al. (2002). In vitro selection of resistance in Haemophilus influenzae by amoxicillin-clavulanate, cefpodoxime, cefprozil, azithromycin, and clarithromycin. Antimicrobial Agents and Chemotherapy 46, 2956-62.
4. Sanchez, L., Pan, W., Vinas, M. et al. (1997). The acrAB homolog of Haemophilus influenzae codes for a functional multidrug efflux pump. Journal of Bacteriology 179, 6855-7.
5. Zgurskaya, H. I. & Nikaido, H. (2000). Multidrug resistance mechanisms: drug efflux across two membranes. Molecular Microbiology 37, 219-25.
6. National Committee for Clinical Laboratory Standards. (2000). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Approved Standard M7-A4. NCCLS, Wayne, PA, USA.
7. Barcak, G. J., Chandler, M. S., Redfield, R. J. at al. (1991). Genetic systems in Haemophilus influenzae. Methods in Enzymology 204, 321-42.
8. Fleischmann, R. D., Adams, M. D., White, O. et al. (1995). Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 269, 496-512.
9. Malbruny, B., Canu, A., Bozdogan, B. et al. (2002). Resistance to quinupristin-dalfopristin due to mutation of L22 ribosomal protein in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 46, 2200-7.
10. Canu, A., Malbruny, B., Coquemont, M. et al. (2002). Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 46, 125-31.
11. Zengel, J. M., Jerauld, A., Walker, A. et al. (2003). The extended loops of ribosomal proteins L4 and L22 are not required for ribosome assembly or L4-mediated autogenous control. RNA 9, 1188-97.
12. Unge, J., Aberg, A., Al-Kharadaghi, S. et al. (1998). The crystal structure of ribosomal protein L22 from Thermus thermophilus: insights into the mechanism of erythromycin resistance. Structure 6, 1577-86.
13. Oethinger, M., Kern, W. V., Jellen-Ritter, A. S. et al. (2000). Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump. Antimicrobial Agents and Chemotherapy 44, 10-13.
14. Guex, N. & Peitsch, M. C. (1997). SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18, 2714-23.